| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| MIR10B |
|
microRNA 10b
|
|
|
0.509 |
0.808 |
| VN1R17P |
Q8TDU5
|
vomeronasal 1 receptor 17 pseudogene
|
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| CYTB |
P00156
|
cytochrome b
|
|
|
0.529 |
0.808 |
| MIR34B |
|
microRNA 34b
|
|
|
0.509 |
0.808 |
| GPR166P |
|
G protein-coupled receptor 166 pseudogene
|
|
|
0.531 |
0.923 |
| MIR200A |
|
microRNA 200a
|
|
|
0.519 |
0.808 |
| MIR486-1 |
|
microRNA 486-1
|
|
|
0.521 |
0.808 |
| MIR106A |
|
microRNA 106a
|
|
|
0.524 |
0.846 |
| TMX2-CTNND1 |
|
TMX2-CTNND1 readthrough (NMD candidate)
|
|
|
0.538 |
0.769 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| CBSL |
P0DN79 P35520
|
cystathionine beta-synthase like
|
|
|
0.540 |
0.808 |
| MIR26B |
|
microRNA 26b
|
|
|
0.529 |
0.808 |
| ND3 |
P03897
|
NADH dehydrogenase, subunit 3 (complex I)
|
|
|
0.604 |
0.654 |
| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
| MIR196B |
|
microRNA 196b
|
|
|
0.561 |
0.731 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
| MT1JP |
|
metallothionein 1J, pseudogene
|
|
|
0.588 |
0.731 |
| MIR421 |
|
microRNA 421
|
|
|
0.592 |
0.692 |
| PSS |
|
Potocki-Shaffer syndrome
|
|
|
0.608 |
0.654 |
| RAB7B |
Q96AH8
|
RAB7B, member RAS oncogene family
|
|
|
0.615 |
0.731 |